Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Neurovascular Centre, Divisions of Therapeutic Neuroradiology and Neurosurgery, St. Michael's Hospital, University of Toronto, ON, Canada.
Eur Stroke J. 2024 Jun;9(2):328-337. doi: 10.1177/23969873231219412. Epub 2024 Feb 26.
Mechanical thrombectomy (MT) has revolutionized the treatment of acute ischemic stroke (AIS) due to large vessel occlusion (LVO), but its efficacy and safety in medium vessel occlusion (MeVO) remain less explored. This multicenter, retrospective study aims to investigate the incidence and clinical outcomes of vessel perforations (confirmed by extravasation during an angiographic series) during MT for AIS caused by MeVO.
Data were collected from 37 academic centers across North America, Asia, and Europe between September 2017 and July 2021. A total of 1373 AIS patients with MeVO underwent MT. Baseline characteristics, procedural details, and clinical outcomes were analyzed.
The incidence of vessel perforation was 4.8% (66/1373). Notably, our analysis indicates variations in perforation rates across different arterial segments: 8.9% in M3 segments, 4.3% in M2 segments, and 8.3% in A2 segments ( = 0.612). Patients with perforation had significantly worse outcomes, with lower rates of favorable angiographic outcomes (TICI 2c-3: 23% vs 58.9%, < 0.001; TICI 2b-3: 56.5% vs 88.3%, < 0.001). Functional outcomes were also worse in the perforation group (mRS 0-1 at 3 months: 22.7% vs 36.6%, = 0.031; mRS 0-2 at 3 months: 28.8% vs 53.9%, < 0.001). Mortality was higher in the perforation group (30.3% vs 16.8%, = 0.008).
This study reveals that while the occurrence of vessel perforation in MT for AIS due to MeVO is relatively rare, it is associated with poor functional outcomes and higher mortality. The findings highlight the need for increased caution and specialized training in performing MT for MeVO. Further prospective research is required for risk mitigation strategies.
机械取栓 (MT) 极大地改变了大血管闭塞 (LVO) 所致急性缺血性脑卒中 (AIS) 的治疗方法,但对于中等血管闭塞 (MeVO) 的疗效和安全性仍研究较少。这项多中心、回顾性研究旨在探讨 MT 治疗 MeVO 所致 AIS 时血管穿孔(通过血管造影系列证实外渗)的发生率和临床结局。
本研究的数据来自 2017 年 9 月至 2021 年 7 月北美、亚洲和欧洲的 37 个学术中心。共纳入 1373 例 MeVO 所致 AIS 患者行 MT。分析基线特征、手术细节和临床结局。
血管穿孔的发生率为 4.8%(66/1373)。值得注意的是,我们的分析表明不同动脉节段穿孔率存在差异:M3 段为 8.9%,M2 段为 4.3%,A2 段为 8.3%( = 0.612)。穿孔患者的结局明显较差,血管造影结局良好的比例较低(TICI 2c-3:23%比 58.9%, < 0.001;TICI 2b-3:56.5%比 88.3%, < 0.001)。穿孔组的功能结局也较差(3 个月 mRS 0-1:22.7%比 36.6%, = 0.031;3 个月 mRS 0-2:28.8%比 53.9%, < 0.001)。穿孔组死亡率较高(30.3%比 16.8%, = 0.008)。
本研究表明,MT 治疗 MeVO 所致 AIS 时血管穿孔的发生率虽然相对较低,但与不良功能结局和较高死亡率相关。这些发现强调了在进行 MeVO 取栓时需要更加谨慎,并进行专门的培训。需要进一步开展前瞻性研究以制定风险缓解策略。